^
RET mutation
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
A1
CStone Pharma Press Release - 2wk
No biomarker
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A1
RET mutation
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
A1
No biomarker
Thyroid Gland Medullary Carcinoma
vandetanib
Sensitive
:
A1
No biomarker
Thyroid Gland Medullary Carcinoma
dacarbazine
Sensitive
:
A2
No biomarker
Thyroid Gland Medullary Carcinoma
denosumab
Sensitive
:
A2
No biomarker
Thyroid Gland Medullary Carcinoma
cabozantinib tablet
Sensitive
:
A2
TMB-H
Thyroid Gland Medullary Carcinoma
pembrolizumab
Sensitive
:
A2
RET M918T
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A2
KRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A2
NRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A2
HRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A2
RET mutation
Thyroid Gland Medullary Carcinoma
TPX 0046
Sensitive
:
C2
RET V804*
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
C3
RET C634*
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
C3
RET M918T
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive
:
C3
RET C634R
Thyroid Gland Medullary Carcinoma
sorafenib
Sensitive
:
C3
RET M918T
Thyroid Gland Medullary Carcinoma
sorafenib
Sensitive
:
C3
RET V804M
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
C3
RET M918T
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
C3
RET V804L
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive
:
C3
RET V804M + RET M918T + RET G810 + RET Y806
Thyroid Gland Medullary Carcinoma
selpercatinib
Resistant
:
C4
NF1 mutation
Thyroid Gland Medullary Carcinoma
vandetanib
Sensitive
:
C4
RET M918T
Thyroid Gland Medullary Carcinoma
everolimus + vandetanib
Sensitive
:
C4
ATM S978fs*12
Thyroid Gland Medullary Carcinoma
everolimus + vandetanib
Sensitive
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our